Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews


Bionano Genomics has priced its initial public offering of 3.36 million units at $6.125 per unit, bringing in total gross proceeds of $20.58 million, and has started trading on the Nasdaq. Each unit consists of one share of common stock and a five-year warrant to purchase another share of common stock at $6.125. The San Diego-based company also granted its underwriters a 30-day option to purchase up to 504,000 additional units at the IPO price.

Read more ...

The U.S. Food and Drug Administration permitted marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder (OCD). “Transcranial magnetic stimulation has shown its potential to help patients suffering from depression and headaches,” said Carlos Peña, Ph.D., M.S., director of the Division of Neurological and Physical Medicine Devices in the FDA’s Center for Devices and Radiological Health. “With marketing authorization, patients with OCD who have not responded to traditional treatments now have another option.”

Read more ...
Funding will help accelerate commercialization of the TruDx 3000, Akonni’s fully-integrated, sample-to-answer diagnostic system. Akonni Biosystems, a molecular diagnostics (MDx) company that develops, manufactures, and intends to market advanced MDx systems, announced receipt of a $3 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).
Read more ...

Recombinetics, a pioneer in gene-editing solutions for human health and animal agriculture, announced the completion of a $34 million Series A financing round. “We’re pleased to announce the successful completion of our Series A Round,” said Tammy Lee, President and CEO of Recombinetics. “This financing will allow us to accelerate commercialization of this transformative science to help find cures for human diseases, develop new regenerative medicine products and breed animals that are healthier and more productive.” 

Read more ...

Company brings FDA cleared, clinical-grade and continuous monitoring to patients' homes. VitalConnect, a player in wearable biosensor technology for wireless monitoring, announced the launch of VistaTabletTM, which ushers in the next-generation of its Vista SolutionTM platform for real-time patient monitoring.

Read more ...
In order to better understand important biological membranes, it is necessary to explore new methods. Researchers at TU Wien (Vienna) have succeeded in creating an artificial placental barrier on a chip, using a high-resolution 3D printing process. The placenta has an essential and highly complex task: it must ensure the exchange of important substances between the mother and her unborn child, whilst simultaneously blocking other substances from passing through.
Read more ...

Upcoming Events

> Lab-on-a-Chip and Microfluidics World Congress 2018
(October 1 - October 3, Coronado Island, California)

> Precision CRISPR Congress
(October 22 - October 24, London, UK)

> Medical MEMS and Sensors 2018
(November 7 - November 8, Santa Clara, USA)


Point of Need Testing & Liquid Biopsy Technology and Market Overview:Challenges, market trends and new solutions
Discover the presentation held by Asma Siari at LOAC Europe 2018, on June 5, 2018, in Rotter...
Convergence of Biosensors and mHealth: application trends and market opportunities
Discover the presentation held by Jérôme Mouly at IEK Forum 2018, on May 22nd 2018, in Tai...
When wearables meet connected healthcare: ready for a disruption?
Discover the presentation held by Benjamin Roussel at Medical Wearables 2018, on May 17th 20...

Access to all our presentations